About USAMRIID

Scientific Publications

Business Opportunities

Employment

Education & Training

Biological Safety

Unified Culture Collection

Reference Materials

Related Links

Newsroom/Media

Contact Us

Search

>>  Home  >>  Scientific Publications  >>  2006

2015 • 2014 • 2013 • 2012 • 2011 • 2010 • 2009 • 2008 • 2007 •
2006 • 2005 • 2004 • 2003 • 2002 • 2001 • 2000

— 2006 —

Aldis JW, Kortepeter MG, Rusnak JM.  2006.  Reaction after smallpox vaccination.  Am Fam Physician 74:145-147.

Amemiya K, Meyers JL, Trevino SR, Chanh TC, Norris SL, Waag DM.  2006.  Interleukin-12 induces a Th1-like response to Burkholderia mallei and limited protection in BALB/c mice.  Vaccine 24:1413-1420.

Bedwell DW, Wolcott MJ, Newell SW, Carpenter J, Chuvala LJ, Scherer JM.  2006.  Identification and differentiating of Francisella tularensis by automated ribotyping.  Abstracts of the 106th General Meeting of the American Society for Microbiology, p629.

Bode EA, Chase CJ, Payne RR, Gibson C, Norwood DA, Scherer JM, Geyer JA, Wasieloski LP.  2006.  Fragmentation utility of target DNA for microarray hybridization.  Abstracts of the 106th General Meeting of the American Society for Microbiology, p630.

Christensen DR, Hartman LJ, Loveless BM, Frye MS, Shipley MA, Bridge DL, Richards MJ, Kaplan RS, Garrison J, Baldwin CD, Kulesh DA, Norwood DA.  2006.  Detection of biological threat agents by real-time PCR: comparison of assay performance on the R.A.P.I.D., the LightCycler, and the Smart Cycler platforms.  Clin Chem 52:141-145.

Daddario-DeCaprio KM, Geisbert TW, Stroher U, Geisbert JB, Grolla A, Fritz EA, Fernando L, Kagan E, Jahrling PB, Hensley LE, Jones SM, Feldmann H.  2006.  Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment.  Lancet 367:1399-1404.

Fuller CL, Brittingham KC, Hepburn MJ, Martin JW, Pettit PL, Pittman PR, Bavari S.  2006.  Dominance of human innate immune responses in primary Francisella tularensis live vaccine strain vaccination. Letter to the editor.  J Allergy Clin Immunol 117:1186-1188.

Geisbert TW, Hensley LE, Kagan E, Yu EZ, Geisbert JB, Daddario-Decaprio K, Fritz EA, Jahrling PB, McClintock K, Phelps JW, Lee AC, Judge A, Jeffs LB, Maclachlan I.  2006.  Postexposure protection of guinea pigs against a lethal Ebola virus challenge is conferred by RNA interference.  J Infect Dis 193:1650-1657.

Gilsdorf J, Gul N, Smith LA.  2006.  Expression, purification, and characterization of Clostridium botulinum type B light chain.  Protein Expr Purif 46:256-267.

Hepburn MJ, Kortepeter MG, Pittman PR, Boudreau EF, Mangiafico JA, Buck PA, Norris SL, Anderson EL.  2006.  Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine.  Vaccine 24:2843-2849.

Hepler RW, Kelly R, McNeely TB, Fan H, Losada MC, George HA, Woods A, Cope LD, Bansal A, Cook JC, Zang G, Cohen SL, Wei X, Keller PM, Leffel E, Joyce JG, Pitt L, Schultz LD, Jansen KU, Kurtz M.  2006.  A recombinant 63-kDa form of Bacillus anthracis protective antigen produced in the yeast Saccharomyces cerevisiae provides protection in rabbit and primate inhalational challenge models of anthrax infection.  Vaccine 24:1501-1514.

Hooper JW, Custer DM, Smith J, Wahl-Jensen V.  2006.  Hantaan/Andes virus DNA vaccine elicits a broadly cross-reactive neutralizing antibody response in nonhuman primates.  Virology 347:208-216.

Jiang G, Joshi B, Peek LJ, Brandau DT, Huang J, Ferriter MS, Woodley WD, Ford BM, Mar KD, Mikszta JA, Huang CR, Ulrich R, Harvey NG, Middaugh CR, Sullivan VJ.  2006.  Anthrax vaccine powder formulations for nasal mucosal delivery.  J Pharm Sci 95:80-96.

Jones T, Adamovicz JJ, Cyr SL, Bolt CR, Bellerose N, Pitt LM, Lowell GH, Burt DS.  2006.  Intranasal Protollin/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection.  Vaccine 24:1625-1632.

Kalina WV, Anderson ML, Gershwin LJ.  2006.  Alternaria aerosol during a bovine respiratory syncytial virus infection alters the severity of subsequent re-infection and enhances IgE production.  Comp Immunol Microbiol Infect Dis 29:138-156.

Kende M, Del Guidice G, Rivera N, Hewetson J.  2006.  Enhancement of intranasal vaccination in mice with deglycosylated chain A ricin by LTR72, a novel mucosal adjuvant.  Vaccine 24:2213-2221.

Krakauer T, Buckley M.  2006.  Dexamethasone attenuates staphylococcal enterotoxin B-induced hypothermic response and protects mice from superantigen-induced toxic shock.  Antimicrob Agents Chemother 50:391-395.

Kuhn JH, Radoshitzky SR, Guth AC, Warfield KL, Li W, Vincent MJ, Towner JS, Nichols ST, Bavari S, Choe H, Aman MJ, Farzan M.  2006.  Conserved receptor-binding domains of lake Victoria marburgvirus and zaire ebolavirus bind a common receptor.  J Biol Chem 281:15951-15958.

Lawler JV, Endy TP, Hensley LE, Garrison A, Fritz EA, Lesar M, Baric RS, Kulesh DA, Norwood DA, Wasieloski LP, Ulrich MP, Slezak TR, Vitalis E, Huggins JW, Jahrling PB, Paragas J.  2006.  Cynomolgus macaque as an animal model for severe acute respiratory syndrome.  PLoS Med 3:e194.

Lee MS, Olson MA.  2006.  Calculation of absolute protein-ligand binding affinity using path and endpoint approaches.  Biophys J 90:864-877.

Little SF, Ivins BE, Webster WM, Fellows PF, Pitt MLM, Norris SL, Andrews GP.  2006.  Duration of protection of rabbits after vaccination with Bacillus anthracis recombinant protective antigen vaccine.  Vaccine 24:2530-2536.

Merino I, Thompson JD, Millard CB, Schmidt JJ, Pang YP.  2006.  Bis-imidazoles as molecular probes for peripheral sites of the zinc endopeptidase of botulinum neurotoxin serotype A.  Bioorg Med Chem 14:3583-3591.

Meyers JL, Worsham PL, Powell B, Norris SL, Krieg AM, Adamovicz JJ, Amemiya K.  2006.  CpG ODNs enhance the efficacy of the Yersinia pestis F1-V vaccine assessed by parenteral and aerosol challenges in a BALB/c murine model for plague.  Abstracts of the 106th General Meeting of the American Society for Microbiology, p241.

Mohamadzadeh M, Coberley SS, Olinger GG, Kalina WV, Ruthel G, Fuller CL, Swenson DL, Pratt WD, Kuhns DB, Schmaljohn AL.  2006.  Activation of triggering receptor expressed on myeloid cells-1 on human neutrophils by marburg and ebola viruses.  J Virol 80:7235-7244.

Moody KL, Cote CK, Blank TE, Friedlander AM, Bozue JA.  2006.  Ccpa of B-anthracis affects catabolite repression, sporulation and germination, but not virulence.  Abstracts of the 106th General Meeting of the American Society for Microbiology, p81.

Moody KL, Parthasarathy N, Friedlander AM, Driks A, Bozue JA.  2006.  Biochemical analysis of Bacillus anthracis spores from fully virulent Strains.  Abstracts of the 106th General Meeting of the American Society for Microbiology, p194.

Mudunuri U, Stephens R, Bruining D, Liu D, Lebeda FJ.  2006.  botXminer: mining biomedical literature with a new web-based application.  Nucleic Acids Res 34:W748-W752.

Muehlenbein MP, Cogswell FB, James MA, Koterski J, Ludwig GV.  2006.  Testosterone correlates with Venezuelan equine encephalitis virus infection in macaques.  Virol J 3:19.

Palacios G, Briese T, Kapoor V, Jabado O, Liu Z, Venter M, Zhai J, Renwick N, Grolla A, Geisbert TW, Drosten C, Towner J, Ju J, Paweska J, Nichol ST, Swanepoel R, Feldmann H, Jahrling PB, Lipkin WI.  2006.  MassTag polymerase chain reaction for differential diagnosis of viral hemorrhagic fever.  Emerg Infect Dis 12:692-695.

Park JG, Sill PC, Makiyi EF, Garcia-Sosa AT, Millard CB, Schmidt JJ, Pang Y-P.  2006.  Serotype-selective, small-molecule inhibitors of the zinc endopeptidase of botulinum neurotoxin serotype A.  Biorg Med Chem 14:395-408.

Pittman PR, Norris SL, Barrera Oro JG, Bedwell D, Cannon TL, McKee Jr KT.  2006.  Patterns of antibody response in humans to the anthrax vaccine adsorbed (AVA) primary (six-dose) series.  Vaccine 24:3654-3660.

Powell B.  2006.  Analyzing vaccines: vaccines are complicated mixtures that provide analytical challenges.  Chem Engin News 84:52-54.

Reed DS, Martinez MJ.  2006.  Respiratory immunity is an important component of protection elicited by subunit vaccination against pneumonic plague.  Vaccine 24:2383-2389.

Ribot WJ, Powell BS, Ivins BE, Little SF, Johnson WM, Hoover TA, Norris SL, Adamovicz JJ, Friedlander AM, Andrews GP.  2006.  Comparative vaccine efficacy of different isoforms of recombinant protective antigen against Bacillus anthracis spore challenge in rabbits.  Vaccine 24:3469-3476.

Ribot WJ, Ulrich RL.  2006.  The animal pathogen-like type III secretion system is required for the intracellular survival of Burkholderia mallei within J774.2 macrophages.  Infect Immun 74:4349-4353.

Rivera VR, Gamez FJ, Keener WK, White JA, Poli MA.  2006.  Rapid detection of Clostridium botulinum toxins A, B, E, and F in clinical samples, selected food matrices, and buffer using paramagnetic bead-based electrochemiluminescence detection.  Anal Biochem 353:248 - 256.

Salierno JD, Snyder NS, Murphy AZ, Poli M, Hall S, Baden D, Kane AS.  2006.  Harmful algal bloom toxins alter c-Fos protein expression in the brain of killifish, Fundulus heteroclitus.  Aqua Toxicol 78:350-357.

Santi L, Giritch A, Roy CJ, Marillonnet S, Klimyuk V, Gleba Y, Webb R, Arntzen CJ, Mason HS.  2006.  Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system.  Proc Natl Acad Sci USA 103:861-866.

Spik K, Shurtleff A, McElroy AK, Guttieri MC, Hooper JW, Schmaljohn C.  2006.  Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus.  Vaccine 24:4657-4666.

Sullivan NJ, Geisbert TW, Geisbert JB, Shedlock DJ, Xu L, Lamoreaux L, Jerome H, Custers HV, Popernack PM, Yang Z-Y, Pau MG, Roederer M, Koup RA, Goudsmit J, Jahrling PB, Nabel GJ.  2006.  Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GSs.  PLoS Med 3:865 - 873.

Trevino SR, Permenter AR, England MJ, Parsatharathy N, Gibbs PH, Waag DM, Chanh TC.  2006.  Monoclonal antibodies passively protect BALB/c mice against Burkholderia mallei aerosol challenge.  Infect Immun 74:1958-1961.

Turell MJ, Dohm DJ, Fernandez R, Calampa C, O'Guinn ML.  2006.  Vector competence of Peruvian mosquitoes (Diptera: Culicidae) for a subtype IIIC virus in the Venezuelan equine encephalomyelitis complex isolated from mosquitoes captured in Peru.  J Am Mosq Control Assoc 22:70-75.

Turell MJ, Mores CN, Dohm DJ, Komilov N, Paragas J, Lee JS, Shermuhemedova D, Endy TP, Kodirov A, Khodjaev S.  2006.  Laboratory transmission of Japanese encephalitis and west Nile viruses by molestus form of Culex pipiens (Diptera: Culicidae) collected in Uzbekistan in 2004.  J Med Entomol 43:296-300.

Ulrich MP, Christensen DR, Coyne SR, Craw PD, Henchal EA, Sakai SH, Swenson D, Tholath J, Tsai J, Weir AF, Norwood DA.  2006.  Evaluation of the Cepheid GeneXpert® system for detecting Bacillus anthracis.  J Appl Microbiol 100:1011-1016.

Ulrich MP, Norwood DA, Christensen DR, Ulrich RL.  2006.  Using real-time PCR to specifically detect Burkholderia mallei.  J Med Microbiol 55:551-559.

Ulrich RL, Ulrich MP, Schell MA, Kim HS, DeShazer D.  2006.  Development of a polymerase chain reaction assay for the specific identification of Burkholderia mallei and differentiation from Burkholderia pseudomallei and other closely related Burkholderiaceae.  Diagn Microbiol Infect Dis 55:37-45.

Vietri NJ, Purcell BK, Lawler JV, Leffel EK, Rico P, Gamble CS, Twenhafel NA, Ivins BE, Heine HS, Sheeler R, Wright ME, Friedlander AM.  2006.  Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax.  Proc Natl Acad Sci USA (epub ahead of print).

Waag DM, McCluskie MJ, Zhang N, Krieg AM.  2006.  A CpG oligonucleotide can protect mice from a low aerosol challenge dose of Burkholderia mallei.  Infect Immun 74:1944-1448.

Wang D, Raja NU, Trubey CM, Juompan LY, Luo M, Woraratanadharm J, Deitz SB, Yu H, Swain BM, Moore KM, Pratt WD, Hart MK, Dong JY.  2006.  Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.  J Virol 80:2738-2746.

Wang D, Schmaljohn AL, Raja NU, Trubey CM, Juompan LY, Luo M, Deist SB, Yu H, Woraratanadharm J, Holman DH, Moore KM, Swain BM, Pratt WD, Dong JY.  2006.  De novo syntheses of Marburg virus antigens from adenovirus vectors induce potent humoral and cellular immune responses.  Vaccine 24:2975-2986.

Warfield KL, RG Panchal, MJ Aman, S Bavari.  2006.  Antisense treatments for biothreat agents.  Curr Opin Mol Ther 8:93-103.

Warfield KL, Swenson DL, Olinger GG, Nichols DK, Pratt WD, Blouch R, Stein DA, Aman MJ, Iverson PL, Bavari S.  2006.  Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.  MPLoS Pathog 2:5-9.

Yu Y, Kim HS, Chua HH, Lin CH, Sim SH, Lin D, Derr A, Engels R, DeShazer D, Birren B, Nierman WC, Tan P.  2006.  Genomic patterns of pathogen evolution revealed by comparison of Burkholderia pseudomallei, the causative agent of melioidosis, to avirulent Burkholderia thailandensis.  BMC Microbiol 6:1-17.

2015 • 2014 • 2013 • 2012 • 2011 • 2010 • 2009 • 2008 • 2007 • 2006 • 2005 • 2004 • 2003 • 2002 • 2001 • 2000

Return to top

Privacy & Security Notice  |  External Links Disclaimer  |  Information Collected  |  Freedom of Information Act (FOIA)
Web Accessibility  |  Accessibility/Section 508  |  Last Modified:  October 1, 2010

This Web site provides an introduction to the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and contains official information.
It is intended for interested members of the public, news media and Army Medical Department beneficiaries.
Please address questions and concerns about this website to the USAMRIID Webmaster via email.